NACL Industries Limited has informed the exchanges about the unaudited financial results
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 22 Jul 2026, 01:54 PM IST · BSE ID: 9d633d2f-4932-4e2b-8c9d-c6e7108151e0
View Original BSE Filing (PDF)
💡
In Simple Terms
NACL Industries approved its latest financial results and decided to sell its share in Nasense Labs Private Limited for over ₹8 Crore.
🤖 AI Summary
- Board approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27).
- Board approved Statement of Deviation(s) and Variation(s) for Rights Issue funds utilized from December 2025.
- Divestment of entire equity stake in Associate Company Nasense Labs Private Limited approved for ₹8,15,29,967.
- Nasense Labs Private Limited contributed 10.93% to turnover and 18.12% to net worth for FY25.
- Proposed sale of Nasense Labs Private Limited is to Mr. Kanumuru Satyanarayana Raju, not a promoter group member.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Nasense Labs Private Limited Turnover / Revenue / Income (FY25)
13,505 Lakhs
Nasense Labs Private Limited Turnover / Revenue / Income Percentage (FY25)
10.93%
Nasense Labs Private Limited Net Worth (FY25)
7,742 Lakhs
Nasense Labs Private Limited Net Worth Percentage (FY25)
18.12%
Sale Consideration for Nasense Labs Private Limited
₹8,15,29,967
🏢 How This Affects the Company
The divestment of Nasense Labs Private Limited will remove its 10.93% contribution to the company's FY25 turnover/revenue, impacting the consolidated business portfolio.
The company will receive ₹8,15,29,967 from the sale of Nasense Labs Private Limited, which contributed 18.12% to its net worth in FY25. This will alter the consolidated balance sheet.
Post-transaction, Nasense Labs Private Limited will cease to be an Associate Company, streamlining the company's operational structure by removing one entity.
The sale is not a related party transaction and the buyer is not from the promoter group, reducing potential governance-related risks associated with such divestments.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the approved financial results and the company's strategic decision to divest an associate company that contributed 10.93% to FY25 turnover.
🔍
Management Signal
Management is signaling a strategic decision to streamline operations and potentially reallocate capital by divesting an associate company.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Completion of Nasense Labs divestment within the next three months.
Next quarter's financial results to assess impact of divestment.
Updates on the utilization of funds from the Rights Issue.
LOW RISK
The filing reports standard board approvals and a non-related party divestment, presenting no immediate elevated risks.
💡 Investor Takeaway
NACL Industries approved Q1 FY27 financial results and divested its entire equity stake in Nasense Labs Private Limited for ₹8,15,29,967. Nasense Labs contributed 10.93% to the company's FY25 turnover/revenue and 18.12% to its net worth.
⚖️ Strengths & Concerns
✅ Positives
- Approval of financial results for Q1 FY27 provides transparency regarding recent performance to stakeholders.
- Divestment of Nasense Labs for ₹8,15,29,967 provides cash inflow and focuses the company's core operations.
⚠️ Concerns
- Removal of Nasense Labs, which contributed 10.93% to FY25 turnover, reduces the consolidated revenue base.
- Nasense Labs represented 18.12% of the company's net worth in FY25, indicating a significant divestment relative to past financials.
📅 Company Track Record
NACL Industries Ltd's Board previously convened on April 27, 2026, to approve its FY26 audited financial results, with the trading window closed until May 6, 2026. This filing follows the approval of Q1 FY27 results.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What financial results did NACL Industries Ltd approve on July 22, 2026?
NACL Industries Ltd approved its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
What is the sale consideration for NACL Industries' stake in Nasense Labs Private Limited?
The total sale consideration for NACL Industries' entire equity stake in Nasense Labs Private Limited is ₹8,15,29,967.
Who is purchasing NACL Industries' stake in Nasense Labs Private Limited?
Mr. Kanumuru Satyanarayana Raju is the proposed buyer of NACL Industries' stake in Nasense Labs Private Limited.
What was Nasense Labs Private Limited's contribution to NACL Industries' FY25 financials?
Nasense Labs Private Limited contributed 10.93% to NACL Industries' turnover/revenue/income and 18.12% to its net worth during the last financial year ended March 31, 2025.
Questions based on this BSE filing only. For information purposes.